AMRX - Amneal Pharmaceuticals Inc (AMRX) CEO Rob Stewart on Q4 2018 Results - Earnings Call Transcript
Amneal Pharmaceuticals, Inc. (AMRX)
Q4 2018 Results Earnings Conference Call
February 28, 2019, 08:30 AM ET
Company Participants
Mark Donohue - Vice President, Investor Relations and Corporate Communications
Rob Stewart - President and Chief Executive Officer
Todd Branning - Chief Financial Officer
Paul Bisaro - Executive Chairman
Andy Boyer - Executive Vice President, Commercial Operations
Joe Todisco - Senior Vice President of Specialty Commercial
David Buchen - Chief Labor Officer and Corporate Secretary
Conference Call Participants
Randall Stanicky - RBC Capital Markets
David Risinger - Morgan Stanley
Louise Chen - Cantor Fitzgerald
Chris Schott -